Depression in Parkinson's Disease

An Update

Jeana L. Benton, Steven Phillip Wengel, William J. Burke

Research output: Contribution to journalArticle

Abstract

Depression is the most common psychological disturbance that affects people with Parkinson's disease (PD). Despite an increasing amount of research devoted to this topic, uncertainty still exists concerning many aspects of depression in PD. Significant questions remain regarding some very basic issues, including how best to diagnose depression in PD, how frequently depression complicates PD, the risk factors for developing depression, and how best to treat depression. This chapter provides a current perspective on what is known about depression in PD, reviewing its epidemiology, etiology, and treatment. Rather than providing a comprehensive overview, the focus here is on updating the major themes of research in this field.

Original languageEnglish (US)
Pages (from-to)3-15
Number of pages13
JournalMilestones in Drug Therapy
Volume24
DOIs
StatePublished - 2013

Fingerprint

Parkinson Disease
Research
Uncertainty
Epidemiology
Psychology

Keywords

  • Depression
  • Dysthymia
  • Electroconvulsive therapy
  • Mania
  • Mesocorticolimbic pathway
  • Nortriptyline
  • Parkinson's disease
  • Paroxetine
  • Pramipexole
  • Selective serotonin reuptake inhibitor
  • Subthalamic nucleus deep brain stimulation
  • Tricyclic anti-depressant

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Drug Discovery

Cite this

Depression in Parkinson's Disease : An Update. / Benton, Jeana L.; Wengel, Steven Phillip; Burke, William J.

In: Milestones in Drug Therapy, Vol. 24, 2013, p. 3-15.

Research output: Contribution to journalArticle

Benton, Jeana L. ; Wengel, Steven Phillip ; Burke, William J. / Depression in Parkinson's Disease : An Update. In: Milestones in Drug Therapy. 2013 ; Vol. 24. pp. 3-15.
@article{d1e57e727ba143199b0c6cd8ca2e39e0,
title = "Depression in Parkinson's Disease: An Update",
abstract = "Depression is the most common psychological disturbance that affects people with Parkinson's disease (PD). Despite an increasing amount of research devoted to this topic, uncertainty still exists concerning many aspects of depression in PD. Significant questions remain regarding some very basic issues, including how best to diagnose depression in PD, how frequently depression complicates PD, the risk factors for developing depression, and how best to treat depression. This chapter provides a current perspective on what is known about depression in PD, reviewing its epidemiology, etiology, and treatment. Rather than providing a comprehensive overview, the focus here is on updating the major themes of research in this field.",
keywords = "Depression, Dysthymia, Electroconvulsive therapy, Mania, Mesocorticolimbic pathway, Nortriptyline, Parkinson's disease, Paroxetine, Pramipexole, Selective serotonin reuptake inhibitor, Subthalamic nucleus deep brain stimulation, Tricyclic anti-depressant",
author = "Benton, {Jeana L.} and Wengel, {Steven Phillip} and Burke, {William J.}",
year = "2013",
doi = "10.1007/978-1-60761-429-6_1",
language = "English (US)",
volume = "24",
pages = "3--15",
journal = "Milestones in Drug Therapy",
issn = "2296-6056",
publisher = "Springer Science + Business Media",

}

TY - JOUR

T1 - Depression in Parkinson's Disease

T2 - An Update

AU - Benton, Jeana L.

AU - Wengel, Steven Phillip

AU - Burke, William J.

PY - 2013

Y1 - 2013

N2 - Depression is the most common psychological disturbance that affects people with Parkinson's disease (PD). Despite an increasing amount of research devoted to this topic, uncertainty still exists concerning many aspects of depression in PD. Significant questions remain regarding some very basic issues, including how best to diagnose depression in PD, how frequently depression complicates PD, the risk factors for developing depression, and how best to treat depression. This chapter provides a current perspective on what is known about depression in PD, reviewing its epidemiology, etiology, and treatment. Rather than providing a comprehensive overview, the focus here is on updating the major themes of research in this field.

AB - Depression is the most common psychological disturbance that affects people with Parkinson's disease (PD). Despite an increasing amount of research devoted to this topic, uncertainty still exists concerning many aspects of depression in PD. Significant questions remain regarding some very basic issues, including how best to diagnose depression in PD, how frequently depression complicates PD, the risk factors for developing depression, and how best to treat depression. This chapter provides a current perspective on what is known about depression in PD, reviewing its epidemiology, etiology, and treatment. Rather than providing a comprehensive overview, the focus here is on updating the major themes of research in this field.

KW - Depression

KW - Dysthymia

KW - Electroconvulsive therapy

KW - Mania

KW - Mesocorticolimbic pathway

KW - Nortriptyline

KW - Parkinson's disease

KW - Paroxetine

KW - Pramipexole

KW - Selective serotonin reuptake inhibitor

KW - Subthalamic nucleus deep brain stimulation

KW - Tricyclic anti-depressant

UR - http://www.scopus.com/inward/record.url?scp=84899447509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899447509&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-429-6_1

DO - 10.1007/978-1-60761-429-6_1

M3 - Article

VL - 24

SP - 3

EP - 15

JO - Milestones in Drug Therapy

JF - Milestones in Drug Therapy

SN - 2296-6056

ER -